common.study.topics.clinical

Testing Experimental Medication in Healthy Subjects

common.study.values.description

Open-label, Crossover, Food Effect Study to Evaluate CT-044 in Healthy Human Volunteers

This open-label study will be conducted to assess the bioavailability and PK of oral single doses of CT-044 following administration with and without food and to evaluate the safety and tolerability of CT-044 when given with and without food.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - CT-044

CT-044 HCl is a reactive species decomposition accelerant

participant.views.study.view.additional

participant.views.study.view.scientific-title

Open-label, Crossover, Food Effect Study to Evaluate the Single Dose Pharmacokinetics of CT-044, a Reactive Species Decomposition Accelerant, in Healthy Human Volunteers

common.study.values.clinical-trial-id

NCT04252833

participant.views.study.view.id

e31knb